AVE 50.0% 0.3¢ avecho biotechnology limited

Here is the rest of the announcement! Phosphagenics’ Chief...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 20,333 Posts.
    lightbulb Created with Sketch. 1796
    Here is the rest of the announcement!

    Phosphagenics’ Chief Executive Officer, Dr Ross Murdoch, added, “We have been
    working hard to build a body of data demonstrating the utility and flexibility of TPM® in
    the Animal Health sector. We have maintained a multi-prong approach assessing
    TPM®’s potential across multiple species selecting three: pigs, poultry and cattle, to
    provide proof-of-concept data in monogastric (single stomach) and ruminant species –
    although related, each being significantly valuable in their own right. To date we have
    demonstrated significant utility and value for TPM® in both the pig and poultry feed sector.
    Discussions with key potential partners have highlighted poultry as a key species of
    interest, increasing the importance of this result. This trial further reinforces our previous
    strong data and adds a new driver for TPM®’s inclusion in the lucrative poultry feed
    market.”
    A trial of the utility of TPM® in dairy cattle feed is nearing completion and headline results are expected before the end of the year.
    Last edited by moosey: 15/12/17
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(50.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $52 21.66K

Buyers (Bids)

No. Vol. Price($)
11 6846739 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41919123 29
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.